Henry Schein Reports Record Fourth Quarter And Full Year 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Harry and Meghan surprised by King Charles' letter on their status
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Qualcomm to issue warrant to Amazon for up to 25M shares
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Henry Schein (HSIC) PT Lowered to $65 at Stifel
February 21, 2019 9:11 AM ESTStifel analyst Jonathan Block lowered the price target on Henry Schein (NASDAQ: HSIC) to $65.00 (from $85.00) while maintaining a Hold rating following the company's 4Q. Results were lighter than expected. Adjusted internal sales growth of +2.6% was below +4.8% estimates, and the 4Q18 two-year stacked adjusted... More
Henry Schein (HSIC) PT Lowered to $59 at Baird
February 21, 2019 8:54 AM ESTBaird analyst Jeff Johnson lowered the price target on Henry Schein (NASDAQ: HSIC) to $59.00 (from $66.00) while maintaining a Neutral rating. Organic revenue growth of +3.1% finished above pre-call estimates of +2.4%. However, organic growth in two of HSIC's higher-margin segments finished below expectations, contributing... More
Henry Schein (HSIC) Tops Q4 EPS by 1c, Revenues Miss; Offers FY19 EPS Guidance Below Consensus
February 20, 2019 7:03 AM ESTHenry Schein (NASDAQ: HSIC) reported Q4 EPS of $1.12, $0.01 better than the analyst estimate of $1.11. Revenue for the quarter came in at $3.38 billion versus the consensus estimate of $3.46 billion.
"This has been a historic year at Henry Schein as we further positioned the company to advance our 2018 to 2020 strategic plan. This included the creation of our Henry Schein One dental technology business, the spin-off of our animal health business into Covetrus (CVET) and restructuring efforts, which together are strategically positioning Henry Schein for continued success," said Stanley M. Bergman,... More
